Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

2 terminated/withdrawn out of 10 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

40%

4 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4

4(57.1%)

N/A

3(42.9%)

7Total

Phase 4(4)

N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT04011566Unknown

Assessment of ShuntCheck Performance Characteristics in Asymptomatic Patients With Normal Pressure Hydrocephalus

Role: collaborator

NCT04309383Unknown

ShuntCheck Performance Characteristics in Asymptomatic Pseudotumor Cerebri Patients

Role: collaborator

NCT04309487Unknown

Diagnostic Accuracy of ShuntCheck Compared to Radionuclide Shunt: Patency in Patients With Normal Pressure Hydrocephalus

Role: collaborator

NCT03705299Not ApplicableCompleted

Non-Invasive CVP Method to Standard CVP Method

Role: collaborator

NCT01323764Phase 4Completed

ShuntCheck Versus Radionuclide in Evaluating Shunt Function in Symptomatic NPH Patients

Role: lead

NCT01881711Phase 4Unknown

ShuntCheck-Micro-Pumper Pediatric Clinical Outcomes Study

Role: lead

NCT00583336Not ApplicableUnknown

Physician Preference Study of ShuntCheck - Madsen

Role: lead

NCT02067364Not ApplicableUnknown

CRT ShuntCheck "Fit & Function" Study

Role: lead

NCT00788385Phase 4Withdrawn

Multi-Center Study of ShuntCheck

Role: lead

NCT00793416Phase 4Withdrawn

ShuntCheck Accuracy in Detecting Shunt Obstruction Normal Pressure Hydrocephalus (NPH) Patients

Role: lead

All 10 trials loaded